Search
Contact
04.02.2025 | Deal Notifications

KPMG Law advises ROTOP shareholders in connection with an investment by GENUI and SHS Capital

KPMG Law Rechtsanwaltsgesellschaft mbH (KPMG Law) provided legal advice to the shareholders of ROTOP Pharmaka GmbH (ROTOP), a provider of development and manufacturing capacities for radiodiagnostics and radiotherapeutics, based in Dresden-Rossendorf, on the negotiations regarding a participation of the healthcare specialists GENUI and SHS Capital.

ROTOP was founded in 1990 and is a supplier of radiopharmaceutical products. ROTOP manufactures cGMP-compliant radiopharmaceuticals for diagnostics and therapy in the fields of nuclear medicine and molecular imaging and distributes them in more than 40 countries worldwide. The market for radiopharmaceuticals has developed considerable momentum in recent years. Two years ago, ROTOP started to expand its CDMO (Contract Development & Manufacturing Organization) offering in order to meet the increasing demand and to be able to cover the clinical and commercial need for batch capacities in the future. GENUI and SHS Capital are participating in the investments. As part of the project, the KPMG Law team provided legal advice to the ROTOP shareholders on the structuring of GENUI’s and SHS’s investment, including the drafting and negotiation of transaction-related documents up to the successful closing. Advisors to ROTOP: KPMG Law Rechtsanwaltsgesellschaft mbH: Inke Reuter (partner, overall responsibility), Dr. Matthias Aldejohann (partner), Marcel Rogg (manager) and Aline Wogawa (manager).

Explore #more

14.10.2025 | Deal Notifications

KPMG Law and KPMG advise Bühler Motor GmbH on the sale of Bühler Motor Aviation GmbH to Astronics Germany GmbH

KPMG Law Rechtsanwaltsgesellschaft (KPMG Law) and KPMG AG Wirtschaftsprüfungsgesellschaft (KPMG) have advised Bühler Motor GmbH on the sale of all shares in Bühler Motor Aviation…

10.10.2025 | In the media

KPMG Law guest article in NZG: Compliance due diligence in SMEs: Minimum scope and contractual mapping of compliance risks of the target company

In the context of M&A transactions, compliance usually still plays a subordinate role in legal due diligence. The purpose of this article is, on…

10.10.2025 | In the media

KPMG Law honored at the M&A Award Night 2025

KPMG Law has been awarded the “M&A Transaction Advisory” prize at this year’s M&A Award Night of the Bundesverband Mergers & Acquisitions e.V. (BM&A) and…

10.10.2025 | In the media

KPMG Law guest article in CCZ: The guide for compliance management systems in small and medium-sized enterprises (DIN SPEC 91524)

Compliance in SMEs is challenging: the legal responsibility for compliance is undisputed, but the specific tasks are unclear and depend on the specific situation of…

10.10.2025 | KPMG Law Insights

Transformation in legal departments in 2026 – the most important trends and best practices

Three topics in particular are currently driving the transformation of the legal department: AI, the rapid increase in regulation and geopolitical developments. There has always…

08.10.2025 | Deal Notifications

KPMG advised Adiuva Capital GmbH with Fact Books on the sale of KONZMANN Group

KPMG Law Rechtsanwaltsgesellschaft mbH (KPMG Law) and KPMG AG Wirtschaftsprüfungsgesellschaft (KPMG) advised Adiuva Capital GmbH, a Hamburg-based private equity firm (“Adiuva“), in connection with the…

06.10.2025 | KPMG Law Insights

What the Green Claims Directive means for companies – an overview

With the Green Claims Directive, the EU will introduce extensive regulations on the requirements for permissible environmental claims. The aim is to prevent greenwashing so…

03.10.2025 | Deal Notifications

KPMG Law and KPMG support the restructuring of Groupe CAT in Germany

KPMG Law Rechtsanwaltsgesellschaft (KPMG Law) and KPMG AG Wirtschaftsprüfungsgesellschaft (KPMG) advised Groupe CAT on comprehensive restructuring measures with a cross-service team. Over a period of…

02.10.2025 | Deal Notifications

KPMG Law advises Epitype GmbH and MDG Molecular Diagnostics Group GmbH on the acquisition of significant assets of oncgnostics GmbH

KPMG Law Rechtsanwaltsgesellschaft mbH (KPMG Law) provided comprehensive legal advice to Epitype GmbH, a company of the Dresden-based MDG Group, on the formation and subsequent…

02.10.2025 | In the media

KPMG Law Statement in ZEIT for entrepreneurs: We’ll take the 500 billion!

German construction companies are asking themselves: how quickly will the money come from the government? And they are worried that only the giants will benefit.…

© 2024 KPMG Law Rechtsanwaltsgesellschaft mbH, associated with KPMG AG Wirtschaftsprüfungsgesellschaft, a public limited company under German law and a member of the global KPMG organisation of independent member firms affiliated with KPMG International Limited, a Private English Company Limited by Guarantee. All rights reserved. For more details on the structure of KPMG’s global organisation, please visit https://home.kpmg/governance.

 KPMG International does not provide services to clients. No member firm is authorised to bind or contract KPMG International or any other member firm to any third party, just as KPMG International is not authorised to bind or contract any other member firm.

Scroll